Abstract
The successful treatment of cancer by boron neutroncapture therapy (BNCT) requires the selective concentration ofboron-10 within malignant tumors. The potential of liposomesto deliver boron-rich compounds to tumors has beenassessed by examination of the biodistribution of borondelivered by liposomes in tumor-bearing mice. Small unilamellarvesicles have been found to stably encapsulate highconcentrations of water-soluble ionic boron compounds. Alternatively, lipophilicboron-containing species have been embedded within the phospholipidbilayer of liposomes, and both hydrophilic and lipophilicboron compounds have been incorporated within the sameliposome formulation.The biodistribution of boron was determined at severaltime points over 48 hr after i.v. injection ofliposomal suspensions in BALB/c mice bearing EMT6 tumors.The tumor-selective delivery of boron by the liposomeswas demonstrated as tumor-boron concentrations increased for severalhours post-injection. Even at the low injected dosesemployed (6–18 mg boron/kg body weight) therapeutic tumor boronconcentrations were observed (>30 μg boron/g tissue) andhigh tumor/blood ratios were achieved (>5). The mostfavorable results were obtained with the polyhedral boraneNa3[a2-B20H17NH2CH2CH2NH2]. Liposomes encapsulating this species produced a tumorboron concentration of 45 μg/g tissue at 30hr post-injection,at which time the tumor/blood boron ratio was9.3.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hawthorne MF: The role of chemistry in the development of boron neutron capture therapy of cancer. Angew Chem Int Ed Engl 32: 950–984, 1993
Coderre JA, Kalef-Ezra JA, Fairchild RG, Micca PL, Reinstein LE, Glass JD: Boron neutron capture therapy of a murine melanoma. Cancer Res 48: 6313–6316, 1988
Clendonn NR, Barth RF, Gordon WA, Goodman JH, Alam F, Staubus AE, Boesel CP, Yates AJ, Moeschberger ML, Fairchild RG, Kalef-Ezra JA: Boron neutron capture therapy of a rat glioma. Neurosurgery 26: 47–55, 1990
Gabel D, Holstein H, Larsson B, Gille L, Ericson G, Sacker D, Som P, Fairchild RG: Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron-containing compounds. Cancer Res 47: 5451–454, 1987
Hatanaka H: A revised boron neutron capture therapy for malignant brain tumors. J Neurology 209: 81–94, 1975
Straubinger RM, Papahadjopoulos D, Hong K: Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry 29: 4929–4939, 1990
Gabel D, Foster S, Fairchild RG: The Monte Carlo simulation of the biological effect of the 10B[n,?)7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiat Res 111: 14–25, 1987
Shelly K, Feakes DA, Hawthorne MF, Schmidt PG, Krisch TA, Bauer WF: Model studies directed toward the boron neutron capture therapy of cancer: boron delivery of murine tumors with liposomes. Proc Natl Acad Sci USA 89: 9039–9043, 1992
Feakes DA, Shelly K, Knobler CB, Hawthorne MF: Na3[B20H17NH3]: Synthesis and liposomal delivery to murine tumors. Proc Natl Acad Sci USA 91: 3029–3033, 1994
Feakes DA, Shelly K, Hawthorne MF: Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc Natl Acad Sci USA 92: 1367–1370, 1995
Georgiev EM, Shelly K, Feakes DA, Kuniyoshi J, Romano S, Hawthorne MF: Synthesis of amine derivatives of the polyhedral borane anion [B20H18]4-. Inorg chem 35: 5412–5416, 1996
Johnson DA, Siemer DD, Bauer WF: Determination of nanogram levels of boron in milligram-sized tissue samples by inductively coupled plasma-atomic emission spectroscopy. Anal Chim Acta 270: 223–230, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hawthorne, M.F., Shelly, K. Liposomes as drug delivery vehicles for boron agents. J Neurooncol 33, 53–58 (1997). https://doi.org/10.1023/A:1005713113990
Issue Date:
DOI: https://doi.org/10.1023/A:1005713113990